Tissue Procurement for Biomedical Research

This study is currently recruiting participants.

Verified October 2010 by National Institutes of Health Clinical Center (CC)

First Received on September 12, 2005. Last Updated on October 15, 2010 History of Changes

Sponsor:	National Institute on Aging (NIA)
Information provided by:	National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:	NCT00182858

Purpose

The purpose of this study is to obtain human tissue samples for scientific study.

Condition
Cardiovascular Diseases Cancer Endocrine Diseases Neurological Disorders Arthritis Mental Disorders

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Tissue Procurement

Resource links provided by NLM:

MedlinePlus related topics: Endocrine Diseases Mental Disorders Neurologic Diseases Psychotic Disorders

U.S. FDA Resources

Further study details as provided by National Institutes of Health Clinical Center (CC):

Biospecimen Retention: Samples With DNA

blood, urine, saliva, sweat, pleural, pericardial, ascitic, synovial, cerebrospinal fluids

Estimated Enrollment:	5000
Study Start Date:	February 2003
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Detailed Description:

Researchers frequently need tissue samples (blood, urine, saliva, sweat, or other body fluid/tissue) to help them understand more about a particular disease or process. This protocol is designed to create the opportunity to obtain such samples that would otherwise be discarded during the course of usual clinical care, or alternatively to obtain such samples during patient screening for other studies.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

Community

Criteria

Inclusion Criteria:

18 years of age or older
Identified by the investigator to have a condition of interest (cardiovascular disease, cancer, endocrine disease, neurological disease, arthritis, psychiatric disease) for exploratory studies related to the patient's illness or other feature that offers the possibility of generation of hypotheses for future studies

Exclusion Criteria:

Unwilling to be subjected to diagnostic and/or therapeutic procedures that are not necessary for clinical management
Excessive blood loss in this study plus other research participation and/or clinical evaluation that will result in blood loss of greater than 1 unit (400ml or 1 pint) over an 8 week period
Inability to give informed consent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00182858

Contacts

Contact: NIA Recruiter

410-350-3941

NIAStudiesRecruitment@mail.nih.gov

Locations

United States, Maryland
National Institute on Aging (NIA), Harbor Hospital	Recruiting
Baltimore, Maryland, United States, 21225
Contact: NIA Recruiter 410-350-3941 NIAStudiesRecruitment@mail.nih.gov
Principal Investigator: William B. Ershler, MD

Sponsors and Collaborators

National Institute on Aging (NIA)

Investigators

Principal Investigator:

William B. Ershler, MD

National Institute on Aging, Laboratory of Clinical Investigation

More Information

Additional Information:

National Institute on Aging This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	William B. Ershler, MD, Principle Investigator, Clinical Research Branch, National Institute of Aging
ClinicalTrials.gov Identifier:	NCT00182858 History of Changes
Other Study ID Numbers:	AG0039
Study First Received:	September 12, 2005
Last Updated:	October 15, 2010
Health Authority:	United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Healthy

Additional relevant MeSH terms:

Arthritis
Mental Disorders
Psychotic Disorders
Cardiovascular Diseases
Endocrine System Diseases

Nervous System Diseases
Joint Diseases
Musculoskeletal Diseases
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on February 09, 2012